CAJ | 학술논문

崔尚志（1924—1989），辽宁名医，中西医结合的开拓者，活血化瘀研究的先驱者，毕生从事中西医结合防治冠心病的临床与研究。他参与研制了“冠心1号”等制剂，通过临床系列研究，总结其疗效规律，并率先开展动物实验研究，探讨中药制剂防治冠心病的作用机制。他主张中医“辨病”“辨证”与西医“辨病”相结合的方法辨证论治，以《内经》理论指导冠心病治疗，将冠心病辨为“心痹”病，分别气滞血瘀、气虚血瘀两大主证，并根据冠心病临床合并症不同，再分为阴虚阳亢等八个兼证。
최상지（1924—1989），료녕명의，중서의결합적개탁자，활혈화어연구적선구자，필생종사중서의결합방치관심병적림상여연구。타삼여연제료“관심1호”등제제，통과림상계렬연구，총결기료효규률，병솔선개전동물실험연구，탐토중약제제방치관심병적작용궤제。타주장중의“변병”“변증”여서의“변병”상결합적방법변증론치，이《내경》이론지도관심병치료，장관심병변위“심비”병，분별기체혈어、기허혈어량대주증，병근거관심병림상합병증불동，재분위음허양항등팔개겸증。
Cui Shangzhi (1 924—1 989)was a very famous integrative physician in China.As an integrative pioneer,he started the research on the treatment of blood activating and stasis removing.He devoted all his life to the integrative medicine.Dr.Cui specialized in treating coronary heart disease (CHD)combining Chinese herbs with western medicine.He invented a Chinese herb formula called guanxin 1 with his colleagues,and did a series of clinical and basic researches on it,through which he proved the effect of guanxin 1 on treating CHD and expounded its therapeutic mechanism.Dr.Cui advocated that the syndrome differentiation should combine Chinese medical disease differentiation with syndrome differentiation according to western medical diseases.In Nei Jing,CHD is considered as Xin Bi,and Dr.Cui differentiated the syndromes of Xin Bi into two main syndromes and eight subordi-nate syndromes according to CHD and its morbidity.